Pw. Frankland et al., ACTIVATION OF AMYGDALA CHOLECYSTOKININ(B) RECEPTORS POTENTIATES THE ACOUSTIC STARTLE RESPONSE IN THE RAT, The Journal of neuroscience, 17(5), 1997, pp. 1838-1847
The acoustic startle reflex is a sensitive index of ''anxiety'' and ''
fear.'' Potentiation of startle by conditioned and unconditioned fear
stimuli appears to be mediated by the amygdala. Cholecystokinin(B) (CC
KB) agonists increase ''anxiety'' in laboratory animals and induce ''p
anic'' in humans. Here, we investigate the role CCKB receptor-mediated
mechanisms in the amygdala in the potentiation of startle. First, int
ra-amygdala infusions of the CCKB receptor agonist pentagastrin (0, 0.
01, 0.1, 1, and 10 nM) produced a dose-related potentiation of acousti
c startle responses. At the highest dose, startle amplitudes were incr
eased up to 90% above preinfusion baseline levels. Second, similar inf
usions of pentagastrin had no effect on locomotor activity over the sa
me time course, showing that increases in startle responsivity after i
nfusions of pentagastrin are not attributable to nonspecific changes i
n motor activity. Third, infusions of similar doses of pentagastrin in
to the striatum or nucleus accumbens did not potentiate startle respon
ses. Fourth, pretreatment with the CCKB receptor antagonist L-365,260
(0.1 mg/kg, i.p.) attenuated the potentiation of startle produced by i
ntra-amygdala infusions of pentagastrin. Finally, intra-amygdala infus
ion of the CCKB receptor-selective antagonist PD-135158 (10 mu g) bloc
ked the potentiation of startle produced by i.c.v. infusions of pentag
astrin, suggesting that i.c.v. infusions of pentagastrin potentiate st
artle responses via activation of amygdala CCKB receptors. These resul
ts show that amygdala CCKB receptor-mediated mechanisms are involved i
n the potentiation of acoustic startle responses.